Close

ACOR Financial Facts

Total net revenues: 135.61M
License and royalty revenue: 2.26M
See Full Income Statement

Property and equipment, net of accumulated depreciation: 35.78M
Total current assets: 237.95M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date N/A EPS Growth Rate -139.7% *Last Qtr.
Average EPS % Beat Rate -188.2% Revenue Growth Rate +63.1% *Last Qtr.
Average % Move 1-Wk after EPS -8.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/15/18 Q417 $0.61$1.05 -$0.44$188.4M$174.75M = Details
8/2/18 Q218 $1.40$0.72 +$0.68$153.3M$138.63M = Details
10/22/15 Q315 $0.31$0.15 +$0.16$148.2M$115.52M N/A Details
10/31/18 Q318 $0.17-$0.02 +$0.19$142.81M$82.81M = Details
10/31/17 Q317 $0.43$0.65 -$0.22$141.07M$150.64M = Details
2/14/17 Q416 $0.05$0.11 -$0.06$140.63M$137.9M = Details
7/27/17 Q217 $0.29$0.48 -$0.19$139.44M$140.07M = Details
10/27/16 Q316 -$0.04$0.11 -$0.15$135.61M$134.01M N/A Details